The anti-HIV activity of three 2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4 (3H)-one derivatives acting as non-nucleoside reverse transcriptase inhibitor in vitro

Yaoxue Xuebao

Volumn 45, Issue 2, 2010, Pages 228-234

  Long, Jing ^a,c   Zhang, De Hua ^b   Zhang, Gao Hong ^a   Rao, Zhi Kun ^b   Wang, Yun Hua ^a   Tam, Siu Cheung ^d   He, Yan Ping ^b   Zheng, Yong Tang ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b YUNNAN UNIVERSITY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

AIDS; Anti HIV activity; HIV 1; NNRTIs; Reverse transcriptase; S DABOs

Indexed keywords

NEVIRAPINE; PYRIMIDINONE DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR; RZK 4; RZK 5; RZK 6; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; VIRUS INHIBITION; VIRUS REPLICATION;

ANTI-HIV AGENTS; BENZYL COMPOUNDS; CELL LINE; DRUG RESISTANCE, VIRAL; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; PYRIMIDINONES; REVERSE TRANSCRIPTASE INHIBITORS; VIRUS REPLICATION;

EID: 77950931629     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Palella Jr FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection [J]. N Engl J Med, 1998, 338: 853-860. (Pubitemid 28135961)
2. Ho DD, Bieniasz PD. HIV at 25 [J]. Cell, 2008, 133: 561-565.
3. De Clercq E. Antiviral drug discovery and development: where chemistry meets with biomedicine [J]. Antiviral Res, 2005, 67: 56-75. (Pubitemid 41112622)
4. De Clercq E. Non-nucleoside reverse transcriptase inhibitors (NNRTIs): past, present and future [J]. Chem Biodivers, 2004, 1: 44-64.
5. Sbardella G, Mai A, Artico M, et al. Structure-activity relationship studies on new DABOS: effect of substitutions at pyrimidine C-5 and C-6 positions on anti-HIV-1 activity [J]. Antivir Chem Chemother, 2001, 12: 37-50. (Pubitemid 32611877)
6. Sudbeck EA, Mao C, Vig R, et al. Structure-based design of novel dihydroalkoxybenzyloxopyrimidine derivatives as potent nonnucleoside inhibitors of the human immunodeficiency virus reverse transcriptase [J]. Antimicrob Agents Chemother, 1998, 42: 3225-3233. (Pubitemid 28553745)
7. Vig R, Mao C, Venkatachalam TK, et al. 5-Alkyl-2-[methyl-thiomethyl) thio]-6-(benzyl)-pyrimidin-4-(1H)-ones as potent non-nucleoside reverse transcriptase inhibitors of S-DABO series [J]. Bioorg Med Chem Lett, 1998, 8: 1461-1466.
8. He YP, Chen F, Sun G, et al. 5-Alkyl-2-[(arylandalkyloxyl-carbonyl- methyl)thio]-6-(1-naphthylmethyl) pyrimidin-4-(3H)-ones as an unique HIV reverse transcriptase inhibitors of S-DABO series [J]. Bioorg Med Chem Lett, 2004, 14: 3173-3176.
9. Sun GF, Kuang YY, Chen FE, et al. Non-nucleoside HIV reverse transcriptase inhibitors, part 6: synthesis and anti-HIV activity of novel 2-[(arylcarbonylmethyl)thio]-6-arylthio DABO analogues [J]. Arch Pharm, 2005, 338: 457-461.
10. Sluis-Cremer N, Tachedjian G. Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors [J]. Virus Res, 2008, 134: 147-156.
11. Ji L, Chen FE, De Clercq E, et al. Synthesis and anti-HIV-1 activity evaluation of 5-alkyl-2-alkylthio-6-(arylcarbonyl or alpha-cyanoarylmethyl)-3, 4-dihydropyrimidin-4 (3H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors [J]. J Med Chem, 2007, 50: 1778-1786. (Pubitemid 46626589)
12. Radi M, Falciani C, Contemori L, et al. A multidisciplinary approach for the identification of novel HIV-1 non-nucleoside reverse transcriptase inhibitors: S-DABOCs and DAVPs [J]. Chem Med Chem, 2007, 3: 573-593
13. Rao ZK, Long J, Li C, et al. Synthesis and anti-HIV-1 activity of S-dihydro (alkyloxy) benzyloxypyrimidine derivatives [J]. Monatsh Chem, 2008, 139: 967-974
14. Liu GJ, Wang JP, Xiao JC, et al. Preparation and characterization of three monoclonal antibodies against HIV-1 p24 capsid protein [J]. Cell Mol Immunol, 2007, 4: 203-208.
15. Zhang GH, Wang Q, Chen JJ, et al. The anti-HIV-1 effect of scutellaria [J]. Biochem Biophys Res Commun, 2005, 334: 812-816.
16. Wang JH, Nie HL, Tam SC, et al. Anti-HIV-1 property of trichosanthin correlates with its ribosome inactivating activity [J]. FEBS Lett, 2002, 531: 295-298.
17. Wang Q, Ding ZH, Liu JK, et al. Xanthohumol, a novel anti-HIV-1 agent purified from Hops Humulus lupulus [J]. Antiviral Res, 2004, 64: 189-194. (Pubitemid 39506839)
18. Zheng YT, Ben KL, Jin SW. Anti-HIV-1 activity of trichosanthin, a novel ribosome-inactivating protein [J]. Acta Pharmacol Sin, 2000, 21: 179-181.
19. Pauwels R, Balzarini J, Baba M, et al. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds [J]. J Virol Methods, 1988, 20: 309-321.
20. Wang RR, Gu Q, Wang YH, et al. Anti-HIV-1 activities of compounds isolated from the medicinal plant Rhus chinensis [J]. J Ethnopharmacol, 2008, 117: 249-256.
21. Pang W, Wang RR, Yang LM, et al. Recombinant protein of heptad-repeat HR212, a stable fusion inhibitor with potent anti-HIV action in vitro [J]. Virology, 2008, 377: 80-87.
22. Artico M. Selected non-nucleoside reverse transcriptase inhibitors (NNRTIs): the DABO family [J]. Drugs Fut, 2002, 27: 159-175. (Pubitemid 34475137)
23. Nunberg JH, Schleif WA, Boots EJ, et al. Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors [J]. Virology, 1991, 65: 4887-4892.